Verastem Q4 Earnings Call Highlights [Yahoo! Finance]
Verastem, Inc. (VSTM)
Last verastem, inc. earnings: 10/29 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
verastem.com
Company Research
Source: Yahoo! Finance
million in Q4), with nearly 300 prescribers , strong payer coverage, ~12–14 day time-to-fill and broad early adoption across academic and community settings. Confirmatory development is advancing: enrollment is complete in RAMP 301 (top-line primary analysis expected in mid-2027 ) and the Japan RAMP 201J bridging study showed investigator-assessed response rates of 57% in KRAS-mutant and 22% in KRAS wild-type, with plans to engage PMDA for conditional approval. Balance sheet supports near-term plans — Verastem ended 2025 with $205 million cash (pro forma $234.4 million ) and expects runway into the first half of 2027 while targeting the LGSOC franchise to be self-sustaining in the second half of 2027. Interested in Verastem, Inc.? Here are five stocks we like better. Verastem (NASDAQ:VSTM) executives said the company's transition to a commercial-stage business accelerated in 2025 following FDA approval of AVMAPKI FAKZYNJA CO-PACK, the first treatment specifically approved for
Show less
Read more
Impact Snapshot
Event Time:
VSTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VSTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VSTM alerts
High impacting Verastem, Inc. news events
Weekly update
A roundup of the hottest topics
VSTM
News
- Verastem Inc (VSTM) Q4 2025 Earnings Call Highlights: Transition to Commercial Stage and ... [Yahoo! Finance]Yahoo! Finance
- Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2 [Seeking Alpha]Seeking Alpha
- Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business UpdatesBusiness Wire
VSTM
Earnings
- 3/4/26 - Beat
VSTM
Sec Filings
- 3/4/26 - Form 8-K
- 3/4/26 - Form 10-K
- 2/17/26 - Form SCHEDULE
- VSTM's page on the SEC website